Maynard Um
-
-
-
-
-
-
-
Xeris sues generic drugmakers over Recorlev patents
-
-
-
-
-
-
-
Xeris Pharmaceuticals (XERS) PT Raised to $9 at Leerink Partners
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx
-
-
-
-
-
-
-
Piper Sandler Downgrades Xeris Pharmaceuticals (XERS) to Neutral
-
-
-
448,577 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

